
Driven to Discover. First to Deliver. Advancing HHT Research Together
A Fireside Chat About the HEROIC HHT-301 Trial and What Patients Can Expect
Please join us for a fireside chat with Dr. Darryl Sleep, Chief Medical Officer at Vaderis Therapeutics; Dr. Damien Picard, Senior Medical Director at Vaderis Therapeutics; and Dr. Hanny Al-Samkari, a leading figure in the HHT field, for an engaging conversation about the HEROIC Phase 3 clinical trial and what it could mean for patients.
We’ll share what we learned from the earlier study, published in the New England Journal of Medicine, including how safe the treatment was and how well it worked. We’ll also explain how those results helped shape the HEROIC trial. Most importantly, patients and families will have an opportunity to hear directly from Vaderis and our HHT expert, ask questions, and gain the information they need to consider whether the HEROIC HHT-301 study may be right for them.